Florida Atlantic University   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Boca Raton FL United States (1961)

Organization Overview

First Clinical Trial
2006
NCT00272337
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Charles E, Schmidt College of Medicine at Florida Atlantic University | Florida Atlantic University

Active Ingredients

Drugs in Phase 4 Trials (2)

acetylsalicylic acid (aspirin) (2 trials)

memantine (namenda) (1 trial)

Drugs in Phase 2 Trials (1)

vitamin d3 (1 trial)

Drugs in Other Trials (3)

aripiprazole (abilify) (1 trial)

clonidine (catapres) (1 trial)

ketamine (ketalar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 4)

Asthma (Phase 2)

Atherosclerosis (Phase 4)

Cardiovascular Diseases (Phase 4)

Infarction (Phase 4)

Metabolic Syndrome (Phase 4)

Myocardial Infarction (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 6